Thyrocare Technologies shares fell after promoter Docon Technologies sold around 1.58 crore shares, cutting its stake from 60.92% to 51.02%. Docon remains the diagnostics company’s promoter and holding company.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.